|
Demand from healthcare providers for treatments that are both clinically effective and commercially sustainable continues to put pressure on the pharmaceutical industry’s bottom line. This, combined with increasingly stringent regulations, means drug companies need to redouble efforts to ensure the economic delivery of treatments, and they need to accomplish this without jeopardising the quality or safety of their products. Optimising the use of packaging is an important step towards achieving these goals.
An Evolving Business Environment
A major challenge facing firms is that pharma manufacturing processes and supply chains now need to accommodate both generic, bulk-produced products and newer small batch options. With production becoming increasingly based on demand and pharma companies reducing inventory for many drug lines, a more agile supply chain is essential to ensure operational efficiency.
Addressing these issues will require closer collaboration with packaging suppliers with a deep understanding of material science and a proven ability to create cost-effective, innovative, and robust designs. Offering tailored designs that provide mandatory levels of security at a price that lowers costs is just one part of the process − they also need to be delivered quickly and economically.
|
